Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...

Full description

Bibliographic Details
Main Author: Teixeira, M. (author)
Other Authors: Rodrigues-Santos, P. (author), Garrido, P. (author), Costa, E. (author), Parada, B. (author), Sereno, J. (author), Alves, R. (author), Belo, L. (author), Teixeira, F. (author), Santos-Silva, A. (author), Reis, F. (author)
Format: article
Language:eng
Published: 2021
Subjects:
Apoptosis
Cardiovascular protection
Gene expression
Moderate chronic renal failure
Proliferation/angiogenesis
Online Access:http://hdl.handle.net/10400.14/35042
Country:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/35042

Internet

http://hdl.handle.net/10400.14/35042

Similar Items